id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OPPT-2009-0156-0104,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Test Guidelines: OPPTS 870.1350 Acute Inhalation Toxicity with Histopathology [EPA 712-C-96-291],Supporting & Related Material,Publication - USEPA,2011-06-29T04:00:00Z,2011,6,,,2011-06-29T15:46:05Z,,0,0,0900006480eb3f69
EPA-HQ-OPPT-2009-0156-0099,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.6850 Peripheral Nerve Function [EPA 712-C-96-241],Supporting & Related Material,Publication - USEPA,2011-06-27T04:00:00Z,2011,6,,,2011-06-27T18:40:50Z,,0,0,0900006480e6b7ec
EPA-HQ-OPPT-2009-0156-0102,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.8223 Pharmacokinetic Test [EPA 712-C-96-250],Supporting & Related Material,Publication - USEPA,2011-06-27T04:00:00Z,2011,6,,,2011-06-27T18:40:51Z,,0,0,0900006480e6b7f2
EPA-HQ-OPPT-2009-0156-0096,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.5450 Rodent Dominant Lethal Assay [EPA 712-C-96-227],Supporting & Related Material,Publication - USEPA,2011-06-27T04:00:00Z,2011,6,,,2011-06-27T18:40:50Z,,0,0,0900006480e6b7e2
EPA-HQ-OPPT-2009-0156-0093,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.3150 Subchronic Nonrodent Oral Toxicity--90-Day [EPA 712-C-96-200],Supporting & Related Material,Publication - USEPA,2011-06-27T04:00:00Z,2011,6,,,2011-06-27T18:40:49Z,,0,0,0900006480e6b7cf
EPA-HQ-OPPT-2009-0156-0100,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.6855 Neurophysiology: Sensory Evoked Potentials [EPA 712-C-96-242],Supporting & Related Material,Publication - USEPA,2011-06-27T04:00:00Z,2011,6,,,2011-06-27T18:40:51Z,,0,0,0900006480e6b7ed
EPA-HQ-OPPT-2009-0156-0094,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.5385 In Vivo Mammalian Cytogenetics Tests: Bone Marrow Chromosomal Analysis [EPA 712-C-96-225],Supporting & Related Material,Publication - USEPA,2011-06-27T04:00:00Z,2011,6,,,2011-06-27T18:40:50Z,,0,0,0900006480e6b7e0
EPA-HQ-OPPT-2009-0156-0095,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.5395 In Vivo Mammalian Cytogenetics Tests: Erythrocyte Micronucleus Assay [EPA 712-C-96-226],Supporting & Related Material,Publication - USEPA,2011-06-27T04:00:00Z,2011,6,,,2011-06-27T18:40:50Z,,0,0,0900006480e6b7e1
EPA-HQ-OPPT-2009-0156-0097,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.5460 Rodent Heritable Translocation Assays [EPA 712-C-96-228],Supporting & Related Material,Publication - USEPA,2011-06-27T04:00:00Z,2011,6,,,2011-06-27T18:40:50Z,,0,0,0900006480e6b7e3
EPA-HQ-OPPT-2009-0156-0101,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.7800 Immunotoxicity [EPA 712-C-96-351],Supporting & Related Material,Publication - USEPA,2011-06-27T04:00:00Z,2011,6,,,2011-06-27T18:40:51Z,,0,0,0900006480e6b7f1
EPA-HQ-OPPT-2009-0156-0103,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.8600 Developmental Neurotoxicity Screen [EPA 712-C-96-258],Supporting & Related Material,Publication - USEPA,2011-06-27T04:00:00Z,2011,6,,,2011-06-27T18:40:51Z,,0,0,0900006480e6b7fb
EPA-HQ-OPPT-2009-0156-0098,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.6500 Schedule-Controlled Operant Behavior [EPA 712-C-96-240],Supporting & Related Material,Publication - USEPA,2011-06-27T04:00:00Z,2011,6,,,2011-06-27T18:40:50Z,,0,0,0900006480e6b7eb
EPA-HQ-OPPT-2009-0156-0088,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.6300 Developmental Neurotoxicity Study [EPA 712-C-96-239],Supporting & Related Material,Publication - USEPA,2011-06-24T04:00:00Z,2011,6,,,2011-06-24T15:27:39Z,,0,0,0900006480e6b7ea
EPA-HQ-OPPT-2009-0156-0080,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.7200 Domestic Animal Safety [EPA 712-C-96-349],Supporting & Related Material,Publication - USEPA,2011-06-24T04:00:00Z,2011,6,,,2011-06-24T12:21:41Z,,0,0,0900006480e6b7ee
EPA-HQ-OPPT-2009-0156-0086,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.8500 Toxicokinetic Test [EPA 712-C-96-257],Supporting & Related Material,Publication - USEPA,2011-06-24T04:00:00Z,2011,6,,,2011-06-24T12:21:42Z,,0,0,0900006480e6b7fa
EPA-HQ-OPPT-2009-0156-0076,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.5575 Mitotic Gene Conversion in Saccharomyces cerevisiae [EPA 712-C-96-232],Supporting & Related Material,Publication - USEPA,2011-06-24T04:00:00Z,2011,6,,,2011-06-24T12:21:40Z,,0,0,0900006480e6b7e6
EPA-HQ-OPPT-2009-0156-0083,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.8355 Combined Chronic Toxicity/Carcinogenicity Testing of Respirable Fibrous Particles [EPA 712-C-99-352],Supporting & Related Material,Publication - USEPA,2011-06-24T04:00:00Z,2011,6,,,2011-06-24T12:21:42Z,,0,0,0900006480e6b7f7
EPA-HQ-OPPT-2009-0156-0089,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.7485 Metabolism and Pharmacokinetics [EPA 712-C-95-244],Supporting & Related Material,Publication - USEPA,2011-06-24T04:00:00Z,2011,6,,,2011-06-24T15:27:39Z,,0,0,0900006480e6b7ef
EPA-HQ-OPPT-2009-0156-0081,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.8320 Oral/Dermal Pharmacokinetics [EPA 712-C-96-253],Supporting & Related Material,Publication - USEPA,2011-06-24T04:00:00Z,2011,6,,,2011-06-24T12:21:41Z,,0,0,0900006480e6b7f5
EPA-HQ-OPPT-2009-0156-0075,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.5375 In Vitro Mammalian Cytogenetics [EPA 712-C-96-223],Supporting & Related Material,Publication - USEPA,2011-06-24T04:00:00Z,2011,6,,,2011-06-24T12:21:40Z,,0,0,0900006480e6b7de
EPA-HQ-OPPT-2009-0156-0079,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.6100 Delayed Neurotoxicity of Organophosphorus Substances Following Acute and 28-Day Exposure [EPA 712-C-96-237],Supporting & Related Material,Publication - USEPA,2011-06-24T04:00:00Z,2011,6,,,2011-06-24T12:21:41Z,,0,0,0900006480e6b7e9
EPA-HQ-OPPT-2009-0156-0084,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.8360 Pharmacokinetics of Isopropanal [EPA 712-C-96-255],Supporting & Related Material,Publication - USEPA,2011-06-24T04:00:00Z,2011,6,,,2011-06-24T12:21:42Z,,0,0,0900006480e6b7f8
EPA-HQ-OPPT-2009-0156-0087,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.5380 In Vivo Mammalian Cytogenetics Tests: Spermatogonial Chromosomal Aberrations [EPA 712-C-96-224],Supporting & Related Material,Publication - USEPA,2011-06-24T04:00:00Z,2011,6,,,2011-06-24T15:27:38Z,,0,0,0900006480e6b7df
EPA-HQ-OPPT-2009-0156-0085,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.8380 Inhalation and Dermal Pharmacokinetics of Commercial Hexane [EPA 712-C-96-256],Supporting & Related Material,Publication - USEPA,2011-06-24T04:00:00Z,2011,6,,,2011-06-24T12:21:42Z,,0,0,0900006480e6b7f9
EPA-HQ-OPPT-2009-0156-0091,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.8700 Subchronic Oral Toxicity Test [EPA 712-C-96-259],Supporting & Related Material,Publication - USEPA,2011-06-24T04:00:00Z,2011,6,,,2011-06-24T15:27:40Z,,0,0,0900006480e6b7fc
EPA-HQ-OPPT-2009-0156-0077,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.5900 In Vitro Sister Chromatid Exchange Assay [EPA 712-C-96-234],Supporting & Related Material,Publication - USEPA,2011-06-24T04:00:00Z,2011,6,,,2011-06-24T12:21:41Z,,0,0,0900006480e6b7e7
EPA-HQ-OPPT-2009-0156-0078,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.5915 In Vivo Sister Chromatid Exchange Assay [EPA 712-C-96-235],Supporting & Related Material,Publication - USEPA,2011-06-24T04:00:00Z,2011,6,,,2011-06-24T12:21:41Z,,0,0,0900006480e6b7e8
EPA-HQ-OPPT-2009-0156-0090,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.7600 Dermal Penetration [EPA 712-C-96-350],Supporting & Related Material,Publication - USEPA,2011-06-24T04:00:00Z,2011,6,,,2011-06-24T15:27:40Z,,0,0,0900006480e6b7f0
EPA-HQ-OPPT-2009-0156-0082,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.8340 Oral and Inhalation Pharmacokinetic Test [EPA 712-C-96-254],Supporting & Related Material,Publication - USEPA,2011-06-24T04:00:00Z,2011,6,,,2011-06-24T12:21:42Z,,0,0,0900006480e6b7f6
EPA-HQ-OPPT-2009-0156-0092,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.8800 Morphologic Transformation of Cells in Culture [EPA 712-C-96-260],Supporting & Related Material,Publication - USEPA,2011-06-24T04:00:00Z,2011,6,,,2011-06-24T15:27:40Z,,0,0,0900006480e6b7fd
EPA-HQ-OPPT-2009-0156-0067,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.5195 Mouse Biochemical Specific Locus Test [EPA 712-C-96-216],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T18:26:31Z,,0,0,0900006480e6b7d8
EPA-HQ-OPPT-2009-0156-0063,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.3800 Reproduction and Fertility Effects [EPA 712-C-96-208],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T16:27:23Z,,0,0,0900006480e6b7d6
EPA-HQ-OPPT-2009-0156-0064,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.5140 Gene Mutation in Aspergillus nidulans [EPA 712-C-96-215],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T16:27:23Z,,0,0,0900006480e6b7d7
EPA-HQ-OPPT-2009-0156-0066,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.8300 Dermal Absorption for Compounds That Are Volatile and Metabolized to Carbon Dioxide [EPA 712-C-96-252],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T16:36:42Z,,0,0,0900006480e6b7f4
EPA-HQ-OPPT-2009-0156-0052,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.1100 Acute Oral Toxicity [EPA 712-C-96-190],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T16:27:21Z,,0,0,0900006480e6b7c7
EPA-HQ-OPPT-2009-0156-0057,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.3200 Repeated Dose Dermal Toxicity--21/28 Days [EPA 712-C-96-201],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T16:27:22Z,,0,0,0900006480e6b7d0
EPA-HQ-OPPT-2009-0156-0060,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.3500 Preliminary Developmental Toxicity [EPA 712-C-96-205],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T16:27:22Z,,0,0,0900006480e6b7d3
EPA-HQ-OPPT-2009-0156-0062,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.3700 Prenatal Developmental Toxicity Study [EPA 712-C-96-207],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T16:27:23Z,,0,0,0900006480e6b7d5
EPA-HQ-OPPT-2009-0156-0068,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.5200 Mouse Visible Specific Locus Test [EPA 712-C-96-217],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T18:26:31Z,,0,0,0900006480e6b7d9
EPA-HQ-OPPT-2009-0156-0071,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.5275 Sex-Linked Recessive Lethal Test in Drosophila melanogaster [EPA 712-C-96-220],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T18:26:31Z,,0,0,0900006480e6b7dc
EPA-HQ-OPPT-2009-0156-0072,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.5300 Detection of Gene Mutations in Somatic Cells in Culture [EPA 712-C-96-221],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T18:26:32Z,,0,0,0900006480e6b7dd
EPA-HQ-OPPT-2009-0156-0073,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.5500 Bacterial DNA Damage or Repair Tests [EPA 712-C-96-229],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T18:26:32Z,,0,0,0900006480e6b7e4
EPA-HQ-OPPT-2009-0156-0053,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.1200 Acute Dermal Toxicity [EPA 712-C-96-192],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T16:27:21Z,,0,0,0900006480e6b7c8
EPA-HQ-OPPT-2009-0156-0058,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.3250 Subchronic Dermal Toxicity--90 Days [EPA 712-C-96-202],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T16:27:22Z,,0,0,0900006480e6b7d1
EPA-HQ-OPPT-2009-0156-0059,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.3465 Subchronic Inhalation Toxicity [EPA 712-C-96-204],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T16:27:22Z,,0,0,0900006480e6b7d2
EPA-HQ-OPPT-2009-0156-0070,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.5265 The Salmonella typhimurium Reverse Mutation Assay [EPA 712-C-96-219],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T18:26:31Z,,0,0,0900006480e6b7db
EPA-HQ-OPPT-2009-0156-0074,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.5550 Unscheduled DNA Synthesis in Mammalian Cells in Culture [EPA 712-C-96-230],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T18:26:32Z,,0,0,0900006480e6b7e5
EPA-HQ-OPPT-2009-0156-0054,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.1300 Acute Inhalation Toxicity [EPA 712-C-96-193],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T16:27:21Z,,0,0,0900006480e6b7c9
EPA-HQ-OPPT-2009-0156-0055,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.2600 Skin Sensitization [EPA 712-C-96-197],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T16:27:21Z,,0,0,0900006480e6b7ca
EPA-HQ-OPPT-2009-0156-0056,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.3100 90-Day Oral Toxicity [EPA 712-C-96-199],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T16:27:22Z,,0,0,0900006480e6b7ce
EPA-HQ-OPPT-2009-0156-0061,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.3600 Inhalation Developmental Toxicity [EPA 712-C-96-206],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T16:27:22Z,,0,0,0900006480e6b7d4
EPA-HQ-OPPT-2009-0156-0069,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.5250 Gene Mutation in Neurospora crassa [EPA 712-C-96-218],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T18:26:31Z,,0,0,0900006480e6b7da
EPA-HQ-OPPT-2009-0156-0065,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Draft Guidelines: OPPTS 870.8245 Dermal Pharmacokinetics of DGBE and DGBA [EPA 712-C-96-251],Supporting & Related Material,Publication - USEPA,2011-06-23T04:00:00Z,2011,6,,,2011-06-23T16:27:23Z,,0,0,0900006480e6b7f3
EPA-HQ-OPPT-2009-0156-0051,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.5500 Bacterial DNA Damage or Repair Tests [EPA 712-C-98-229],Supporting & Related Material,Publication - USEPA,2010-07-15T04:00:00Z,2010,7,,,2010-07-15T12:28:50Z,,0,0,0900006480b1a0d3
EPA-HQ-OPPT-2009-0156-0044,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.6850 Peripheral Nerve Function [EPA 712–C–98–241],Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2009-07-09T17:57:18Z,,0,0,09000064809bc931
EPA-HQ-OPPT-2009-0156-0045,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.6855 Neurophysiology: Sensory Evoked Potentials [EPA 712–C–98–242],Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2009-07-09T17:57:21Z,,0,0,09000064809bc932
EPA-HQ-OPPT-2009-0156-0038,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.5900 In Vitro Sister Chromatid Exchange Assay [EPA 712–C–98–234],Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2009-07-09T17:57:01Z,,0,0,09000064809bc908
EPA-HQ-OPPT-2009-0156-0046,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.7200 Companion Animal Safety [EPA 712–C–98–349],Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2009-07-09T17:57:24Z,,0,0,09000064809bc933
EPA-HQ-OPPT-2009-0156-0035,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.5550 Unscheduled DNA Synthesis in Mammalian Cells in Culture [EPA 712-C-98-230] - (Duplicate of EPA-HQ-OPPT-2009-0156-0036),Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2010-07-14T20:17:00Z,,0,0,09000064809bc905
EPA-HQ-OPPT-2009-0156-0036,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.5550 Unscheduled DNA Synthesis in Mammalian Cells in Culture [EPA 712–C–98–230],Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2009-07-09T17:56:56Z,,0,0,09000064809bc906
EPA-HQ-OPPT-2009-0156-0037,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.5575 Mitotic Gene Conversion in Saccharomyces Cerevisiae [EPA 712–C–98–232],Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2009-07-09T17:56:59Z,,0,0,09000064809bc907
EPA-HQ-OPPT-2009-0156-0040,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.6100 Acute and 28-Day Delayed Neurotoxicity of Organophosphorus Substances [EPA 712–C–98–237],Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2009-07-09T17:57:07Z,,0,0,09000064809bc92d
EPA-HQ-OPPT-2009-0156-0041,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.6200 Neurotoxicity Screening Battery [EPA 712–C–98–238],Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2009-07-09T17:57:10Z,,0,0,09000064809bc92e
EPA-HQ-OPPT-2009-0156-0032,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.5395 Mammalian Erythrocyte Micronucleus Test [EPA 712–C–98–226],Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2009-07-09T17:56:42Z,,0,0,09000064809bc902
EPA-HQ-OPPT-2009-0156-0034,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.5460 Rodent Heritable Translocation Assays [EPA 712–C–98–228],Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2009-07-09T17:56:49Z,,0,0,09000064809bc904
EPA-HQ-OPPT-2009-0156-0042,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.6300 Developmental Neurotoxicity Study [EPA 712–C–98–239],Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2009-07-09T17:57:12Z,,0,0,09000064809bc92f
EPA-HQ-OPPT-2009-0156-0047,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.7485 Metabolism and Pharmacokinetics [EPA 712–C–98–244],Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2009-07-09T17:57:26Z,,0,0,09000064809bc934
EPA-HQ-OPPT-2009-0156-0050,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.8355 Combined Chronic Toxicity/Carcinogenicity Testing of Respirable Fibrous Particles [EPA 712–C–01–352],Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2009-07-09T17:57:35Z,,0,0,09000064809bc959
EPA-HQ-OPPT-2009-0156-0039,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.5915 In Vivo Sister Chromatid Exchange Assay [EPA 712–C–98–235],Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2009-07-09T17:57:04Z,,0,0,09000064809bc909
EPA-HQ-OPPT-2009-0156-0043,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.6500 Schedule-Controlled Operant Behavior [EPA 712–C–98–240],Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2009-07-09T17:57:15Z,,0,0,09000064809bc930
EPA-HQ-OPPT-2009-0156-0048,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.7600 Dermal Penetration [EPA 712–C–98–350],Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2009-07-09T17:57:29Z,,0,0,09000064809bc935
EPA-HQ-OPPT-2009-0156-0033,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.5450 Rodent Dominant Lethal Assay [EPA 712–C–98–227],Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2009-07-09T17:56:46Z,,0,0,09000064809bc903
EPA-HQ-OPPT-2009-0156-0049,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.7800 Immunotoxicity [EPA 712–C–98–351],Supporting & Related Material,Publication - USEPA,2009-07-09T04:00:00Z,2009,7,,,2009-07-09T17:57:32Z,,0,0,09000064809bc936
EPA-HQ-OPPT-2009-0156-0012,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.3200 21/28-Day Dermal Toxicity [EPA 712–C–98–201],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:10:08Z,,0,0,09000064809bc449
EPA-HQ-OPPT-2009-0156-0025,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.5200 Mouse Visible Specific Locus Test [EPA 712–C–98–217],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:10:49Z,,0,0,09000064809bc4ac
EPA-HQ-OPPT-2009-0156-0027,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.5275 Sex-linked Recessive Lethal Test in Drosophila Melanogaster [EPA 712–C–98–220],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:10:56Z,,0,0,09000064809bc4ae
EPA-HQ-OPPT-2009-0156-0003,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.1100 Acute Oral Toxicity [EPA 712–C–02–190],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:09:40Z,,0,0,09000064809bc3f7
EPA-HQ-OPPT-2009-0156-0011,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.3150 90-Day Oral Toxicity in Nonrodents [EPA 712–C–98–200],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:10:05Z,,0,0,09000064809bc448
EPA-HQ-OPPT-2009-0156-0004,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.1200 Acute Dermal Toxicity [EPA 712–C–98–192],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:09:43Z,,0,0,09000064809bc440
EPA-HQ-OPPT-2009-0156-0009,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.3050 Repeated Dose 28-day Oral Toxicity Study in Rodents [EPA 712–C–00–366],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:09:59Z,,0,0,09000064809bc445
EPA-HQ-OPPT-2009-0156-0007,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.2500 Acute Dermal Irritation [EPA 712–C–98–196],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:09:52Z,,0,0,09000064809bc443
EPA-HQ-OPPT-2009-0156-0014,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.3465 90-Day Inhalation Toxicity [EPA 712–C–98–204],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:10:15Z,,0,0,09000064809bc483
EPA-HQ-OPPT-2009-0156-0017,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.3700 Prenatal Developmental Toxicity Study [EPA 712–C–98–207],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:10:24Z,,0,0,09000064809bc488
EPA-HQ-OPPT-2009-0156-0021,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.4300 Combined Chronic Toxicity/Carcinogenicity [EPA 712–C–98–212],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:10:37Z,,0,0,09000064809bc4a8
EPA-HQ-OPPT-2009-0156-0023,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.5140 Gene Mutation in Aspergillus nidulans [EPA 712–C–98–215],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:10:43Z,,0,0,09000064809bc4aa
EPA-HQ-OPPT-2009-0156-0020,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.4200 Carcinogenicity [EPA 712–C–98–211],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:10:33Z,,0,0,09000064809bc48b
EPA-HQ-OPPT-2009-0156-0016,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.3650 Combined Repeated Dose Toxicity with the Reproduction/Developmental Toxicity Screening Test [EPA 712–C–00–368],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:10:21Z,,0,0,09000064809bc487
EPA-HQ-OPPT-2009-0156-0018,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.3800 Reproduction and Fertility Effects [EPA 712–C–98–208],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:10:27Z,,0,0,09000064809bc489
EPA-HQ-OPPT-2009-0156-0019,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.4100 Chronic Toxicity [EPA 712–C–98–210],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:10:30Z,,0,0,09000064809bc48a
EPA-HQ-OPPT-2009-0156-0022,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.5100 Bacterial Reverse Mutation Test [EPA 712–C–98–247],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:10:40Z,,0,0,09000064809bc4a9
EPA-HQ-OPPT-2009-0156-0026,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.5250 Gene Mutation in Neurospora Crassa [EPA712–C–98–218],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:10:52Z,,0,0,09000064809bc4ad
EPA-HQ-OPPT-2009-0156-0002,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.1000 Acute Toxicity Testing - Background [EPA 712–C–02–189],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:09:37Z,,0,0,09000064809bc3f6
EPA-HQ-OPPT-2009-0156-0006,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.2400 Acute Eye Irritation [EPA 712–C–98–195],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:09:49Z,,0,0,09000064809bc442
EPA-HQ-OPPT-2009-0156-0024,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.5195 Mouse Biochemical Specific Locus Test [EPA 712–C–98–216],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:10:46Z,,0,0,09000064809bc4ab
EPA-HQ-OPPT-2009-0156-0008,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.2600 Skin Sensitization [EPA 712–C–03–197],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:09:56Z,,0,0,09000064809bc444
EPA-HQ-OPPT-2009-0156-0030,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.5380 Mammalian Spermatogonial Chromosome Aberration Test [EPA 712–C–98–224],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:11:06Z,,0,0,09000064809bc900
EPA-HQ-OPPT-2009-0156-0031,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.5385 Mammalian Bone Marrow Chromosome Aberration Test [EPA 712–C–98–225],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:11:09Z,,0,0,09000064809bc901
EPA-HQ-OPPT-2009-0156-0013,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.3250 90-Day Dermal Toxicity [EPA 712–C–98–202],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:10:11Z,,0,0,09000064809bc482
EPA-HQ-OPPT-2009-0156-0005,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.1300 Acute Inhalation Toxicity [EPA 712–C–98–193],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:09:46Z,,0,0,09000064809bc441
EPA-HQ-OPPT-2009-0156-0010,EPA,EPA-HQ-OPPT-2009-0156,Health Effects Test Guidelines: OPPTS 870.3100 90-Day Oral Toxicity in Rodents [EPA 712–C–98–199],Supporting & Related Material,Publication - USEPA,2009-06-24T04:00:00Z,2009,6,,,2009-06-24T16:10:02Z,,0,0,09000064809bc447